Alerts
FDA Puts AI Inside the Evidence Machine
FDA’s real-time clinical trial initiative with AstraZeneca and Amgen tests whether AI and data science can shorten evidence-review delays, but also raises questions about data quality, oversight and regulatory trust.
Europe Starts Treating Brain Health as System Resilience
Genomic Matching Works When the Evidence Is Strong Enough to Act
Precision Oncology Is Moving Faster Than Europe’s Access Machinery
England’s Cancer Plan Turns Personalised Care Into a National Delivery Test
Cancer Drugs Put Europe’s New HTA System to Its First Real Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.